MedTrace Logo

Effect of Active Drain Line Clearance on Catheter-Associated Bacteriuria

NCT03816384 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2020-01-29

No results posted yet for this study

Summary

Catheter-associated urinary tract infections (CAUTI) are the most common nosocomial infections in critically ill patients and are responsible for high morbidity rates, increased hospital stays and associated costs.

The purpose of this study is to evaluate whether active drain line clearance by the Accuryn Monitoring System reduces the incidence of CAUTI in hospitalized patients requiring catheters.

Conditions

Interventions

DEVICE

Standard of Care

Standard of care urinary drainage system.

DEVICE

DLC Group

Urinary drainage system with active drain line clearance and plain silicone catheter.

DEVICE

DLCS Group

Urinary drainage system with active drain line clearance and silver-doped silicone catheter.

Sponsors & Collaborators

  • Potrero Medical

    lead INDUSTRY

Principal Investigators

  • Kevin Foster, MD · Maricopa Integrated Health System (MIHS)

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-01-31
Primary Completion
2020-01-31
Completion
2020-01-31
FDA Device
Yes

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03816384 on ClinicalTrials.gov